# Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia

> **NCT02328872** · NA · ACTIVE_NOT_RECRUITING · sponsor: **VCS Foundation** · enrollment: 76181 (actual)

## Conditions studied

- Cancer of the Cervix
- Cervical Intraepithelial Neoplasia

## Interventions

- **DEVICE:** Molecular testing for HPV
- **DEVICE:** Liquid Based Cytology

## Key facts

- **NCT ID:** NCT02328872
- **Lead sponsor:** VCS Foundation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-01
- **Primary completion:** 2027-06
- **Final completion:** 2037-03
- **Target enrollment:** 76181 (ACTUAL)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02328872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02328872, "Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02328872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*